Please login to the form below

Not currently logged in
Email:
Password:

Renvela

This page shows the latest Renvela news and features for those working in and with pharma, biotech and healthcare.

Sanofi warns of difficult few months as diabetes sales slump

Sanofi warns of difficult few months as diabetes sales slump

The loss of patent protection for kidney disease drug Renvela/Renagel (sevelamer) also took its toll, according to chief executive Olivier Brandicourt, the architect of the turnaround plan at Sanofi, who

Latest news

  • Generic competition for Sanofi's Renvela hits UK market Generic competition for Sanofi's Renvela hits UK market

    Generic competition for Sanofi's Renvela hits UK market. Teva and others launch cheaper versions of the chronic kidney disease drug. ... That was the exception however as most of the drugs, as with Renvela, saw primary care spending in England in the

  • Genzyme wins Scottish approval for Renvela

    Genzyme wins Scottish approval for Renvela. Genzyme UK can supply Renvela within NHS Scotland after securing Scottish Medicine Consortium approval. ... Renvela is a medication for the control of serum phosphorous in patients with CKD.

  • PM Society Advertising Awards 2010

    Digital Media. Renvela by Langland on behalf of Genzyme. Digital Pioneer. Gary Monk.

  • Trials and tribulations

    Sevelamer carbonate. Renvela (Genzyme Corporation). Hypophosphataemia. US. Hydrocodone/ibuprofen. Ibudone (ProEthic Pharmaceuticals).

  • News in brief, May 02, 2007

    The Waterford site will also produce Genzyme's future products, including Tolevamer (GT160-246), a non-antibiotic toxin-binding polymer for the treatment of Clostridium difficile-associated diarrhoea (CDAD) and Renvela,

More from news
Approximately 1 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Quintiles Medical Communications

Quintiles’ award-winning medical communications group sits at the heart of the enterprise. We offer a range of innovative strategic services,...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics